BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 241815)

  • 1. Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity.
    Winslow E
    Br J Pharmacol; 1980; 71(2):615-22. PubMed ID: 7470765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of the British Pharmacological Society. 16--18th December, 1980.
    Br J Pharmacol; 1981 May; 73(1):175P-318P. PubMed ID: 7284696
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug.
    Campbell TJ; Vaughan Williams EM
    Br J Pharmacol; 1982 Jun; 76(2):337-45. PubMed ID: 7093588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    Br J Pharmacol; 1981 Jun; 73(2):373-7. PubMed ID: 6786403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery ligation in anaesthetized rats as a model for the assessment of antidysrhythmic activity; the effects of lignocaine, propranolol and ORG 6001 [proceedings].
    Kane K; McDonald F; Parratt JR
    Br J Pharmacol; 1979 Jul; 66(3):463P-464P. PubMed ID: 526747
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of aminosteroid, ORG 6001, on hypothermia induced ventricular fibrillation in the cat.
    Kane KA; McDonald FM; Parratt JR
    Br J Pharmacol; 1979 Aug; 66(4):609-18. PubMed ID: 465898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.
    Salako LA; Williams V; Wittig JH
    Br J Pharmacol; 1976 Jun; 57(2):251-62. PubMed ID: 7336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental models for the pharmacologic study of anti-arrhythmia drugs].
    Vainsel H; Dodion L; Bernard R; Denolin H
    Acta Cardiol; 1977; Suppl 22():33-35. PubMed ID: 327735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidysrhythmic and cardiovascular effects of the aminosteroid, ORG 6001.
    Marshall RJ; Winslow E
    Gen Pharmacol; 1981; 12(5):315-22. PubMed ID: 7026350
    [No Abstract]   [Full Text] [Related]  

  • 11. ORG 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride), a steroidal anti-arrhythmic agent.
    Vargaftig BB; Sugrue MF; Buckett WR; van Riezen H
    J Pharm Pharmacol; 1975 Sep; 27(9):697-9. PubMed ID: 241815
    [No Abstract]   [Full Text] [Related]  

  • 12. Local anaesthetic and antiarrhythmic properties of an aminosteroid: 3alpha-dimethyl-amino-5alpha-androstan-2beta-ol-17-one (Org. NA 13).
    Buckett WR; Marwick FA
    Br J Pharmacol; 1975 May; 54(1):3-9. PubMed ID: 1139075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1975 Nov; 55(3):359-68. PubMed ID: 1133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
    Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
    Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.